课题基金 / 基金详情

The Baltimore Longitudinal Study Of Aging

The Baltimore Longitudinal Study Of Aging
巴尔的摩老龄化纵向研究
批准号:
6968648
负责人:
LUIGI FERRUCCI
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

LUIGI FERRUCCI的其他基金

相似基金

相关文献

中文摘要
翻译
巴尔的摩老龄化纵向研究(BLSA)是NIA目前的主要研究项目,自1958年以来一直在老年学研究中心进行,现在活跃于位于巴尔的摩海港医院的NIA- astra(老龄化转化研究)部门。这项研究继续代表着一个致力于描述正常和病理性衰老特征的科学家联盟。目前管理这项研究的研究小组正在对其设计和评估技术进行重大改革。主要的科学目标仍然是最初BLSA遗产中报告的那些:1)确定个体之间不能用疾病解释的年龄相关差异;2)表征影响从正常衰老到病理性衰老转变的因素。然而,正在实施新的措施,目的是更好地了解年龄和疾病对导致许多老年人行动不便和生活质量差的过程的影响。重点是综合和多学科的方法,以及在多个层面(细胞、组织、器官、整个身体、社会)自然实施的补偿机制,使许多老年人尽管有多种病理过程,仍能保持高水平的活动能力。
英文摘要
The Baltimore Longitudinal Study of Aging (BLSA), the Intramural NIA's current major research program on human aging, has been conducted at the Gerontology Research Center since 1958, and is now active at the NIA-ASTRA (Translational Research on Aging) Unit located at Harbor Hospital (Baltimore). The study continues to represent a consortium of scientists who work to characterize normal and pathological aging. The team of researchers currently managing the study is implementing major changes in its design and assessment technology. The primary scientific goals remain those that were reported in the original BLSA legacy: 1) to identify age-associated differences among individuals which are not explained by diseases, and 2) to characterize factors that affect the transitions from normal to pathological aging. However, new measures are being implemented that are aimed at gaining a better understanding of the effect of age and diseases on the process that leads to mobility disability and poor quality of life in many older adults. The focus is on an integrative and multidisciplinary approach, and the compensatory mechanisms that, naturally implemented at multiple levels (cells, tissues, organs, whole body, society) allow many older persons to maintain a high level of mobility, in spite of multiple pathological process. The study population is a cohort of volunteers that are followed for life over multiple follow-up visits. Many of the active participants have been in the study for more than 20 years, and some for as long as 44 years. In the future, a screening program will be implemented to longeve individuals that have maintained an extraordinary high level of physical and congnitive functioning. In the past, the BLSA has been the gold-standard reference for all epidemiological studies on aging. Important findings in the area of cardiovascular research, factors affecting the risk of prostate cancer, age-associated decline of cognitive function, muscle strength and bone strength were published even in recent years. Moving the BLSA to the ASTRA unit was vital to implementing some of the new knowledge in a clinical perspective. This goal will be pursued by conducting, in parallel, the BLSA ancillary studies that, being limited to a small number of participants and adressing a single, pre-formulated hypothesis, are more likely to provide information that can be directly applied in clinical medicine. The structure of the new BLSA design is based on three levels of measures: 1. The reference level is the level of behavior that is mostly influenced by physical and cognitive function. Accordingly, the BLSA includes comprehensive measures of physical and cognitive function from different perspectives; 2. The intermediate level includes measures of anatomical integrity and functionality of the physiological systems that are important for mobility: central nervous system, peripheral nervous system, muscle, bone and joints, delivery of substances important for energy production, sensory systems that provide feedback from the environment; 3. The third level includes the physiological systems that are important to maintain a stable biological homeostasis and include measures for immune function, hormones, oxidative stress/antioxidants, autonomic nervous system, nutritional intake, and physical activity. The hypothesis of the study is that a dysfunction of the systems that maintain the biological homeostasis is the primary cause of the age associated decline of physical function and of the development of frailty.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Baltimore Longitudinal Study Of Aging
  • 批准号:
    7591958
  • 项目类别:
  • 资助金额:
    $630.89万
  • 财政年份:
    --
  • 负责人:
    LUIGI FERRUCCI
  • 依托单位:
The Baltimore Longitudinal Study Of Aging
  • 批准号:
    7732139
  • 项目类别:
  • 资助金额:
    $506.57万
  • 财政年份:
    --
  • 负责人:
    LUIGI FERRUCCI
  • 依托单位:
The Aging Genome Association Study "AGE-GAIN"
  • 批准号:
    7732382
  • 项目类别:
  • 资助金额:
    $22.18万
  • 财政年份:
    --
  • 负责人:
    LUIGI FERRUCCI
  • 依托单位:
Uric Acid and Inflammatory Markers
  • 批准号:
    7327092
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    LUIGI FERRUCCI
  • 依托单位:
国内基金
海外基金
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
  • 批准号:
    82371603
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈晓
  • 依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
  • 批准号:
    82370743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姜娜
  • 依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
  • 批准号:
    82371585
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    周鲁明
  • 依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮渊
  • 依托单位: